Klaudia Kwiatkowski - Concepedia

Author

Klaudia Kwiatkowski

Polish Academy of Sciences ORCID

Also Known As

K. Kwiatkowski, Klaudia Kwiatkowski

Publications

631

Citations

H-Index

Concepts

All Affiliations

Polish Academy of Sciences Maj Institute of Pharmacology Jagiellonian University

About

Klaudia Kwiatkowski is an author at Polish Academy of Sciences specializing in pain medicine, health sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	9	9	435
2	Medicine	9	9	435
3	Neuroscience	5	5	263
4	Immunology	3	3	68
5	Neurology	2	2	141

Klaudia Kwiatkowski

Publications

573

Citations

H-Index

Page 1

	Year	Citations
Maraviroc reduces neuropathic pain through polarization of microglia and astroglia – Evidence from in vivo and in vitro studies Anna Piotrowska, Klaudia Kwiatkowski, Ewelina Rojewska, Neuropharmacology InflammationNeuroinflammationPain DisordersHealth SciencesAstroglia – Evidence	2016	125
Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats Klaudia Kwiatkowski, Anna Piotrowska, Ewelina Rojewska, Progress in Neuro-Psychopharmacology and Biological Psychiatry Beneficial PropertiesPain TherapyOpioid EffectivenessHealth SciencesMedicine	2015	69
Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia Klaudia Kwiatkowski, Katarzyna Popiołek-Barczyk, Anna Piotrowska, Cytokine InflammationPain TherapyPain-related BehaviorHealth SciencesAcute Pain	2019	61
Direct and indirect pharmacological modulation of CCL2/CCR2 pathway results in attenuation of neuropathic pain — In vivo and in vitro evidence Anna Piotrowska, Klaudia Kwiatkowski, Ewelina Rojewska, Journal of Neuroimmunology InflammationMolecular PharmacologyPain ResearchPain DisordersIndirect Pharmacological Modulation	2016	59
The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats Klaudia Kwiatkowski, Anna Piotrowska, Ewelina Rojewska, Journal of Neuroimmune Pharmacology	2017	59
The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain Katarzyna Pawlik, Anna Piotrowska, Klaudia Kwiatkowski, Immunology Pain TherapyPain MedicineImmunologyNeuropathic PainMolecular Pain	2020	35
Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy Klaudia Kwiatkowski, Katarzyna Pawlik, Katarzyna Ciapała, Frontiers in Immunology	2020	32
CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain Joanna Bogacka, Katarzyna Ciapała, Katarzyna Pawlik, Frontiers in Immunology	2020	31
Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses Klaudia Kwiatkowski, Katarzyna Ciapała, Ewelina Rojewska, International Immunopharmacology Molecular PharmacologyPain TherapyHealth SciencesNeuropathic Pain-related SymptomsMedicine	2020	29
Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model Joanna Mika, Agnieszka M. Jurga, Mateusz T. Wasylewski, Neuroscience Amitriptyline AdministrationHealth SciencesNaïve MicePain MedicineMedicine	2015	24

Page 1